A research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado, of the Research Institute of the McGill University Health Centre (RI-MUHC), and Dr. Michael Taylor, of The Hospital for Sick Children (SickKids), discovered that several types of highly aggressive and, ultimately, fatal pediatric brain tumors originate during brain development. The genetic event that triggers the disease happens in the very earliest phases of cellular development, most likely prenatal.

Classified as: Claudia Kleinman, Nada Jabado, Michael Taylor, Lady Davis Institute, jewish general hospital, Research Institute of the McGill University Health Centre, The Hospital for Sick Children, pediatric brain tumors, embryonic cells
Category:
Published on: 25 Nov 2019

An over-reliance on self-report screening questionnaires, wherein patients essentially define their own condition, in place of diagnostic interviews conducted by a health care professional, has resulted in over-estimation of the prevalence of people with depression in many research studies – often by a factor of two to three times. This is according to a study published in the Canadian Medical Association Journal. The study found that over 75% of recent research on depression prevalence has been based exclusively on patient completed questionnaires.

Classified as: McGill University, Brett Thombs, jewish general hospital, Lady Davis Institute, depression, health, mental health
Category:
Published on: 18 Jan 2018

McGill Newsroom

Discovery offers hope for more effective treatments of deadly glioblastomas

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Classified as: neuroscience, brain, Lady Davis Institute, science and technology, tumor, glioblastoma, tumour, Jahani-Asl, OSMR, neuroproject
Published on: 25 Apr 2016
Back to top